News Release

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) and Osaka University (Location: Suita, Osaka, Japan; President: Shojiro Nishio) signed a comprehensive collaboration agreement on May 24, 2019 to foster innovation in the healthcare field by leveraging Sysmex’s diagnostic technologies and the knowledge Osaka University possesses in the field of information science. This agreement, which runs from May 2019 to March 2022, includes joint research and support for student researchers.


Artificial intelligence (AI) and other information technologies are gaining attention as core technologies for innovation needed to create the next-generation industrial structure. In recent years healthcare institutions have been handling an increasing diversity and quantity of data due to such factors as the proliferation of gene testing, which involves massive quantities of genome information, and growing interest in preventive medicine. This explosion in the quantity of data is being accompanied by anticipation of information technologies that can help medical institutions optimize their operations and enhance quality, as well as develop precise diagnostic methods and technologies for predicting drug efficacy, which are needed for personalized medicine.

To reinforce its R&D related to information analysis technology, centered on bioinformatics, Sysmex established a new R&D facility, the Skyfront Research Campus, within the Life Innovation Center, located in the Kawasaki INnovation Gateway at SKYFRONT, in the Tonomachi area of Kawasaki, Kanagawa Prefecture, in 2017.1 Sysmex has also formed an alliance with OPTiM Corporation in the field of “advanced medicine x AI and IoT” to accelerate the development and deployment of IT solutions and platforms to support next-generation healthcare and diagnostics.2 Through initiatives such as these, we are leveraging information technologies to foster innovation in the healthcare field.

In 2016, Osaka University established the Institute for Datability Science to promote the use of big data, cultivate AI and other sophisticated information technologies, and promote interdisciplinary research3 to foster the creation of social, public and economic value. The university is also concentrating on the cultivation of deployment-ready personnel in the AI field by conducting educational courses targeting researchers and engineers.

About the Comprehensive Collaboration Agreement

On May 24, 2019, Sysmex and Osaka University signed a comprehensive collaboration agreement to leverage Sysmex’s diagnostic technologies and the knowledge Osaka University possesses in the field of information science to cultivate new diagnostic technologies for use in personalized medicine and preventive/preemptive medicine, the creation of new healthcare businesses, joint research, and support for student researchers. The agreement, which commenced in May 2019, is slated to last until March 2022.

The joint research is aimed at fostering innovation in the healthcare field. To this end, the two parties will consider and set themes for joint research and then pursue research in these areas. To support student researchers, Osaka University students will be invited to participate in research themes established for joint research or those that Sysmex is pursuing independently. In August, Sysmex will begin hosting such students at Technopark, its R&D hub.

In fiscal 2017, Sysmex also began participating in the Initiative for the Implementation of the Diversity Research Environment (Collaboration Type),4 which is being promoted by Osaka University. Through initiatives to cultivate female researchers, Sysmex will actively encourage female researchers to take part in joint research and support for student researchers under this comprehensive collaboration agreement.

By eliciting synergies between the two parties, Sysmex and Osaka University aim to foster innovation in the healthcare field that leverages sophisticated information technologies, contributing to the advancement of healthcare and the healthy lives of people.


  1. Sysmex Corporation press release of June 1, 2017 entitled “Sysmex Opens New R&D Facility with a View toward the Realization of Personalized Medicine”
  2. Sysmex Corporation press release of February 6, 2019 entitled “Sysmex and OPTiM Enter Alliance in the Area of ‘Advanced Medicine x AI and IoT’ -Accelerating Development and Deployment of IT Solutions and Platforms to Support Next-Generation Healthcare and Diagnostics-”
  3. Interdisciplinary research is a research approach that involves collaboration among researchers in different fields to address issues that are difficult to resolve in a single academic field. Specifically, the Institute for Datability Science encourages interdisciplinary research to promote data-driven research in diverse fields. The institute also targets interdisciplinary research involving collaboration in the humanities, social sciences and information science to address ethical, legal and social risks when using data.
  4. Initiative for the Implementation of the Diversity Research Environment (Collaboration Type): This initiative by the Ministry of Education, Culture, Sports, Science and Technology supports efforts to set organization-wide targets and establish action plans to promote the activities of female researchers, taking institutional and regional characteristics into consideration. The initiative targets institutions that publish and support efforts to create research environments that take into account the life events and work-life balance of female researchers, initiatives for enhancing research capabilities, and active promotion to senior positions.

Information contained in the press release is current as of the date of the announcement, but may be subject to change without prior notice.


You are redirected to a 3rd party website!

Clicking on a social media link implies that you understand you are leaving our site and entering a third-party website. We are not responsible for their content, privacy policies, or terms of use. Please review their terms and privacy policy before proceeding. We do not endorse or control the third-party website and disclaim any liability for damages or consequences.